PPT-Prescribing Pain Medications

A Scientific Approach Christopher Dietrich MD Scope of the Problem 42 of Emergency Room Visits Pain Problems Estimated 44 million pain related visits made to US emergency departments annually. Katy Trinkley, . PharmD. Angie Thompson, . PharmD. Outline . Opioid risks and risk prevention strategies. Medication treatment by pain type. Fundamental principles of opioid therapy. Opioid risks. Opioid prescribing is on the rise. Anthony Oxley – Head of Pharmacy. The Driver for Implementing EPMA?. Mental Health, Learning Disability and Community Health Services.. Prince2 Project . JAC User. Leicestershire Partnership NHS Trust. <Audience>. <Presenter>. < >. Produced by AFS-850. National FAA Safety Team. Welcome. Exits. Restrooms. Emergency Evacuation. Breaks . Sponsor Acknowledgment. Other information. 2. Overview . for . Abuse . of . Controlled Substances . with . e-Prescribing . Dr. James L. Holly, CEO, Southeast Texas Medical Associates, LLP. Adjunct . Professor, . Family and Community Medicine UTHSCSA School of Medicine. Susan Payne, MPH, PhD. Research Professor. Institute for Health . Policy,. Muskie School of Public . Service,. University of Southern Maine. Patricia Lapera, MPH. Prescription Monitoring Program Coordinator,. Tracy Brooks, . PharmD. , BCPS, BCNSP. Assistant Professor of Pharmacy Practice. Member of PRMC’s Palliative Care Team. Member of Indiana RX Task Force. Objectives:. Pharmacists:. Review the terms “legitimate medical purpose” and “corresponding responsibility” as they apply to the use of opioid analgesics in the treatment of chronic pain.. Most painkiller use isn’t . misuse. Effective to treat residual pain after surgery, as well as chronic pain. Highly habit-forming . Deadly at high doses or in conjunction with other drugs. Pain Medications. Fellowship HVC Curriculum 2016-2017 • Presentation 4 of 7. Learning Objectives. Compare efficacy and costs of commonly prescribed medications including generic (and . biosimilar. ) versus non-generic medications.. Fellowship HVC Curriculum 2016-2017 • Presentation 4 of 7. Learning Objectives. Compare efficacy and costs of commonly prescribed medications including generic (and . biosimilar. ) versus non-generic medications.. This presentation is based on . the September 2014. AHRQ . WebM&M. Spotlight Case. See the full article at . http://webmm.ahrq.gov. . CME credit is available. Commentary by: . Shoshana J. Herzig, MD, MPH. . Wael Hamade, MD, FAAFP. . 04/08/2016. DISCLOSURES. None of the faculty, planners, speakers, providers nor CME committee has any relevant financial relationships with commercial interest. Angela Henderson, Dr Deborah Kinnear, Professor Jill Morrison, Associate Professor Linda Allan, Professor Sally-Ann Cooper, Professor Colin McCowan, Kevin Ross. Background. Concern . over the use of . He315@ic.ac.uk. Outline. Prescribing in the OSCEs. Anatomy of the Drug Chart. Using the BNF. Prescribing Medications. Prescribing IV Fluids. Outline. Prescribing in the OSCEs. Anatomy of the Drug Chart. Delivered by / Contact Details. Date. ISD 2017 – January to December 2016 Data. The maps demonstrate change in cost per treated patient since 2012. . Realistic Medicine: Goals. Reducing the burden of overtreatment.